éå»1ã¶æéã«Evaxion Biotech A/Sã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã4åã«åºã¥ãããŒã¿ã
仿ãEVAXã¯4ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããEVAXã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯11.250ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -0.447ã«ç¶ããEVAXã®FY2026Q3ã®EPSã¯-0.293ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD -0.45 ã§ããããEvaxion Biotech A/SEVAX ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.43 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.29 ãšäºæ³ãããŸãã